Development and Delivery of an FDA Licensed Bioscavenger Prophylactic

The U.S. Army Contracting Command Aberdeen Proving Grounds (ACC-APG) Natick Division is providing notice that a Request for Proposal (RFP), W911QY-12-R-0056, for Bioscavenger (BSCAV)/Nerve Agent Prophylactic contract that will meet the requirement for medical countermeasures against the effects of nerve agent chemical warfare threats will be issued on or about 1 June 2012 with an anticipated contract award on or about 27 September 2012. This is a full and open competition and all responsible or qualified sources are eligible to compete.

In accordance with DFARS 252.204-7004, all interested contractors shall be registered in the Central Contractor Registration (CCR) database. CCR registration can be accomplished at the following website: http://www.ccr.gov. The North American Industry Classification System (NAICS) codes for this procurement are 541711, Research and Development in Biotechnology. The Government does not intend to use FAR Part 12 for this acquisition.

The Government intends for the contractor to be regulatory sponsor and system integrator for this effort.

The objective of this procurement is to deliver a countermeasure which is safe, efficacious, quick acting, free from performance-decrementing side effects, relatively non-invasive, approved by the U.S. Food and Drug Administration (FDA), compatible with current military CBRN countermeasures, and usable in contemporary operational environments. The ultimate goal of the Bioscavenger/nerve agent prophylactic countermeasure project is to select, develop, and manufacture a FDA-approved drug/biologic to increase survival and decrease incapacitation such that forces can maintain operational effectiveness within a contaminated area following nerve agent exposure, irrespective of nerve agent type.

Proposals will be evaluated based on Factors and Subfactors, representing the "Best Value" to the Government. Delivery schedule of the product shall be proposed by the offerors and will be used as one of the criteria associated with a Best Value evaluation. Proposed schedule calling for delivery of Bioscavenger (BSCAV)/Nerve Agent Prophylactic is anticipated within 6 years after contract award, but all proposed delivery schedules will be evaluated. All interested parties can view, download, and print a copy of the solicitation and any resulting amendments when released on or about 1 June 2012 at the FedBizOpps website hyperlink https://www.fbo.gov/. Search on solicitation number W911QY-12-R-0056. No paper copies of the RFP will be provided and no mailing list will be maintained because the acquisition will be posted on the above website. Questions or correspondence should be directed by e-mail to leo.fratis@us.army.mil and please reference the RFP number W911QY-12-R-0056.